• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Abbvie Inc`s Biologics Skyrizi Receives Suppl Approval in US

    FDA

    AbbVie’s Elahere Approved in Canada

    HEALTH CANADA

    AbbVie`s Biologics Skyrizi Receives Suppl Approval in US

    FDA

    Abbvie Inc Biologic Risankizumab-Rzaa Receives Approval in US

    FDA

    Abbvie Inc Biologic Risankizumab-Rzaa Receives Suppl Approval in US

    FDA

    AbbVie`s Biologic Skyrizi (risankizumab) Receives Approval in the U.S.

    FDA

    AbbVie`s Biologic Humira (adalimumab) Receives Approval in the U.S.

    FDA

    AbbVie`s Tepkinly (epcoritamab) Receives Approval in Europe

    EMA

    AbbVie`s Skyrizi Receives Approval in Europe

    EMA

    AbbVie`s Biologic SKYRIZI (Risankizumab) Receives Approval in the U.S.

    FDA

    AbbVie`s Erisankizumab-rzaa Receives Supplemental Approval in the U.S.

    FDA

    AbbVie`s Biologic Creon (Pancrelipase) Receives Approval in the U.S.

    FDA

    AbbVie`s Biologic Skyrizi (Risankizumab-rzaa) Receives Approval in the U.S.

    FDA

    Abbvie’s Skyrizi (risankizumab-rzaa) Receives Supplemental Approval In US

    FDA

    Abbvie’s Adalimumab Receives Supplemental Approval In US

    FDA

    AbbVie`s Skyrizi (risankizumab-rzaa) Receives Supplemental Approval in US

    FDA

    AbbVie`s Biological Humira (Adalimumab) Receives Supplemental Approval in US

    FDA

    Abbvie`s Biological Humira (Adalimumab) Receives Approval in US

    FDA

    Abbvie`s Biological Adalimumab Receives Supplemental Approval in US

    FDA

    Abbvie’s Humira (Adalimumab ) Receives Supplemental Approval In US

    FDA

    AbbVie`s Maviret (glecaprevir / pibrentasvir) Receives Approval In Europe

    EMA

    Abbvie’s Adalimumab (Humira) Receives Supplemental Approval In US

    FDA

    Abbvie Gets EU Nod For Venclyxto (Venetoclax)

    AbbVie Receives FDA Approval Of Viekria XR For The Treatment of Genotype 1 Chronic Hepatitis C

    FDA

    Abbvie`s Venclexta(Venetoclax) approved in US for chronic lymphocytic leukemia

    FDA

    AbbVie`s HUMIRA® (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa

    PR NEWS WIRE

    Bristol`s Daklinza (Daclatasvir) Approved in US For Hepatitis C Genotype 3 Infections

    FDA

    Abbvie`s Kaletra (Lopinavir; Ritonavir) Receives Supplemental Approval in US For HIV/AIDS

    FDA

    AbbVie`s Humira (Adalimumab) Approved in Europe For Chronic Plaque Psoriasis

    ABBVIE

    AbbVie`s Viekirax (Ombitasvir/Paritaprevir/Ritonavir) Approved in Europe For Hepatitis C

    EMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.